1. Home
  2. SNX vs RGEN Comparison

SNX vs RGEN Comparison

Compare SNX & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNX
  • RGEN
  • Stock Information
  • Founded
  • SNX 1980
  • RGEN 1981
  • Country
  • SNX United States
  • RGEN United States
  • Employees
  • SNX N/A
  • RGEN N/A
  • Industry
  • SNX Retail: Computer Software & Peripheral Equipment
  • RGEN Medical/Dental Instruments
  • Sector
  • SNX Technology
  • RGEN Health Care
  • Exchange
  • SNX Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • SNX 10.6B
  • RGEN 8.0B
  • IPO Year
  • SNX 2003
  • RGEN N/A
  • Fundamental
  • Price
  • SNX $135.01
  • RGEN $123.57
  • Analyst Decision
  • SNX Strong Buy
  • RGEN Buy
  • Analyst Count
  • SNX 9
  • RGEN 12
  • Target Price
  • SNX $140.89
  • RGEN $170.40
  • AVG Volume (30 Days)
  • SNX 962.4K
  • RGEN 787.0K
  • Earning Date
  • SNX 06-24-2025
  • RGEN 07-29-2025
  • Dividend Yield
  • SNX 1.31%
  • RGEN N/A
  • EPS Growth
  • SNX 19.95
  • RGEN N/A
  • EPS
  • SNX 8.56
  • RGEN N/A
  • Revenue
  • SNX $60,007,297,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • SNX $3.34
  • RGEN $13.93
  • Revenue Next Year
  • SNX $4.55
  • RGEN $14.35
  • P/E Ratio
  • SNX $15.75
  • RGEN N/A
  • Revenue Growth
  • SNX 6.60
  • RGEN 4.88
  • 52 Week Low
  • SNX $92.23
  • RGEN $102.97
  • 52 Week High
  • SNX $145.10
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • SNX 66.79
  • RGEN 48.29
  • Support Level
  • SNX $123.28
  • RGEN $115.86
  • Resistance Level
  • SNX $138.97
  • RGEN $126.61
  • Average True Range (ATR)
  • SNX 3.17
  • RGEN 4.43
  • MACD
  • SNX 1.02
  • RGEN -0.07
  • Stochastic Oscillator
  • SNX 73.81
  • RGEN 42.95

About SNX TD SYNNEX Corporation

TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and data center infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include the Americas, Europe, and APJ.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: